In this study, treatment with TGF-β1 (10 ng/ml, Sigma-Aldrich, USA) for 1 h not significantly inhibited cell proliferation of two cervical squamous cell carcinoma cell lines, but also significantly reduce the enhancing effects of PVT1 overexpression on cell proliferation. Here, PVT1 is linked to cervical squamous cell carcinoma.